Advanced nanoparticulate system for the treatment of antiinflammatory diseases

Nitin Verma; Neha Kanojia; Vivek Puri; Ameya Sharma; Komal Thapa; Lata Rani; Mahesh Gupta; Dinesh Kumar Chellappan; Kamal Dua

doi:10.1016/B978-0-323-99988-5.00020-6

Advanced nanoparticulate system for the treatment of antiinflammatory diseases

Nitin Verma
, Neha Kanojia
, Vivek Puri
, Ameya Sharma
, Komal Thapa
, Lata Rani
, Mahesh Gupta
, Dinesh Kumar Chellappan
, Kamal Dua

Chitkara University
University of Saskatchewan
International Medical University
University of Technology Sydney

Research output: Chapter in Book/Report/Conference proceeding › Chapter › peer-review

Abstract

Inflammation seems to be a critical immune response, which enables survivability in disease and tissue damage. Persistent inflammations are frequently connected with serious negative health consequences. Moreover, the limited solubility and cellular permeability of synthetic medicines, as well as their extreme instability, pose significant challenges in providing prolonged administration. To address these shortcomings, nanocarrier-based conveyance techniques are now being used in the health-care industry for continuous and enhanced delivery. This study considers current advancements in nanocarrier-mediated medication delivery in antiinflammatory therapy.

Original language	English
Title of host publication	Recent Developments in Anti-Inflammatory Therapy
Publisher	Elsevier
Pages	163-169
Number of pages	7
ISBN (Electronic)	9780323999885
ISBN (Print)	9780323914161
DOIs	https://doi.org/10.1016/B978-0-323-99988-5.00020-6
State	Published - 1 Jan 2023
Externally published	Yes

Keywords

Cellular
Chronic inflammation
Micelles
Nanocarrier
Nanoparticle
Tissue damage

Access to Document

10.1016/B978-0-323-99988-5.00020-6

Cite this

@inbook{cf607816d3ac41059ca854cdf7097f8f,

title = "Advanced nanoparticulate system for the treatment of antiinflammatory diseases",

abstract = "Inflammation seems to be a critical immune response, which enables survivability in disease and tissue damage. Persistent inflammations are frequently connected with serious negative health consequences. Moreover, the limited solubility and cellular permeability of synthetic medicines, as well as their extreme instability, pose significant challenges in providing prolonged administration. To address these shortcomings, nanocarrier-based conveyance techniques are now being used in the health-care industry for continuous and enhanced delivery. This study considers current advancements in nanocarrier-mediated medication delivery in antiinflammatory therapy.",

keywords = "Cellular, Chronic inflammation, Micelles, Nanocarrier, Nanoparticle, Tissue damage",

author = "Nitin Verma and Neha Kanojia and Vivek Puri and Ameya Sharma and Komal Thapa and Lata Rani and Mahesh Gupta and Chellappan, \{Dinesh Kumar\} and Kamal Dua",

year = "2023",

month = jan,

day = "1",

doi = "10.1016/B978-0-323-99988-5.00020-6",

language = "English",

isbn = "9780323914161",

pages = "163--169",

booktitle = "Recent Developments in Anti-Inflammatory Therapy",

publisher = "Elsevier",

address = "Netherlands",

}

TY - CHAP

T1 - Advanced nanoparticulate system for the treatment of antiinflammatory diseases

AU - Verma, Nitin

AU - Kanojia, Neha

AU - Puri, Vivek

AU - Sharma, Ameya

AU - Thapa, Komal

AU - Rani, Lata

AU - Gupta, Mahesh

AU - Chellappan, Dinesh Kumar

AU - Dua, Kamal

PY - 2023/1/1

Y1 - 2023/1/1

N2 - Inflammation seems to be a critical immune response, which enables survivability in disease and tissue damage. Persistent inflammations are frequently connected with serious negative health consequences. Moreover, the limited solubility and cellular permeability of synthetic medicines, as well as their extreme instability, pose significant challenges in providing prolonged administration. To address these shortcomings, nanocarrier-based conveyance techniques are now being used in the health-care industry for continuous and enhanced delivery. This study considers current advancements in nanocarrier-mediated medication delivery in antiinflammatory therapy.

AB - Inflammation seems to be a critical immune response, which enables survivability in disease and tissue damage. Persistent inflammations are frequently connected with serious negative health consequences. Moreover, the limited solubility and cellular permeability of synthetic medicines, as well as their extreme instability, pose significant challenges in providing prolonged administration. To address these shortcomings, nanocarrier-based conveyance techniques are now being used in the health-care industry for continuous and enhanced delivery. This study considers current advancements in nanocarrier-mediated medication delivery in antiinflammatory therapy.

KW - Cellular

KW - Chronic inflammation

KW - Micelles

KW - Nanocarrier

KW - Nanoparticle

KW - Tissue damage

UR - https://www.scopus.com/pages/publications/85153421577

U2 - 10.1016/B978-0-323-99988-5.00020-6

DO - 10.1016/B978-0-323-99988-5.00020-6

M3 - Chapter

AN - SCOPUS:85153421577

SN - 9780323914161

SP - 163

EP - 169

BT - Recent Developments in Anti-Inflammatory Therapy

PB - Elsevier

ER -

Advanced nanoparticulate system for the treatment of antiinflammatory diseases

Abstract

Keywords

Access to Document

Other files and links

Fingerprint

Cite this